229 related articles for article (PubMed ID: 1969326)
41. Tissue-specific differences in the levels of proglucagon-derived peptides in streptozotocin-induced diabetes.
Brubaker PL; So DC; Drucker DJ
Endocrinology; 1989 Jun; 124(6):3003-9. PubMed ID: 2721455
[TBL] [Abstract][Full Text] [Related]
42. Do glucagonomas always produce glucagon?
Wewer Albrechtsen NJ; Challis BG; Damjanov I; Holst JJ
Bosn J Basic Med Sci; 2016 Feb; 16(1):1-7. PubMed ID: 26773171
[TBL] [Abstract][Full Text] [Related]
43. Distribution of glucagonlike peptide I (GLP-I), glucagon, and glicentin in the rat brain: an immunocytochemical study.
Jin SL; Han VK; Simmons JG; Towle AC; Lauder JM; Lund PK
J Comp Neurol; 1988 May; 271(4):519-32. PubMed ID: 3385016
[TBL] [Abstract][Full Text] [Related]
44. Expression of peptide hormone genes in human islet cell tumors.
Philippe J; Powers AC; Mojsov S; Drucker DJ; Comi R; Habener JF
Diabetes; 1988 Dec; 37(12):1647-51. PubMed ID: 2903836
[TBL] [Abstract][Full Text] [Related]
45. The endocrine pancreas in patients with insulinomas. An immunocytochemical and ultrastructural study of the nontumoral tissue with morphometrical evaluations.
Bani Sacchi T; Bani D; Biliotti G
Int J Pancreatol; 1989 Jul; 5(1):11-28. PubMed ID: 2568382
[TBL] [Abstract][Full Text] [Related]
46. Morphological changes in the human endocrine pancreas induced by chronic excess of endogenous glucagon.
Bani D; Biliotti G; Sacchi TB
Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(3):199-206. PubMed ID: 1679271
[TBL] [Abstract][Full Text] [Related]
47. GLP-1 and GLP-1(7-36) amide: influences on basal and stimulated insulin and glucagon secretion in the mouse.
Fridolf T; Böttcher G; Sundler F; Ahrén B
Pancreas; 1991 Mar; 6(2):208-15. PubMed ID: 1886889
[TBL] [Abstract][Full Text] [Related]
48. Immunocytochemistry of normal pancreatic islets and spontaneous islet cell tumors in dogs.
Hawkins KL; Summers BA; Kuhajda FP; Smith CA
Vet Pathol; 1987 Mar; 24(2):170-9. PubMed ID: 2883753
[TBL] [Abstract][Full Text] [Related]
49. The role of prohormone convertases PC1 (PC3) and PC2 in the cell-specific processing of proglucagon.
Mineo I; Matsumura T; Shingu R; Namba M; Kuwajima M; Matsuzawa Y
Biochem Biophys Res Commun; 1995 Feb; 207(2):646-51. PubMed ID: 7864855
[TBL] [Abstract][Full Text] [Related]
50. Glicentin and gastric inhibitory polypeptide immunoreactivity in endocrine cells of the gut and pancreas.
Larsson LI; Moody AJ
J Histochem Cytochem; 1980 Sep; 28(9):925-33. PubMed ID: 6997368
[TBL] [Abstract][Full Text] [Related]
51. Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans.
Orskov C; Rabenhøj L; Wettergren A; Kofod H; Holst JJ
Diabetes; 1994 Apr; 43(4):535-9. PubMed ID: 8138058
[TBL] [Abstract][Full Text] [Related]
52. Secretory granules in benign and malignant glucagonomas of the pancreas.
Nakanishi I; Katsuda S; Kajikawa K; Yonemura Y; Konishi K; Miwa K
Acta Pathol Jpn; 1984 Jan; 34(1):95-102. PubMed ID: 6328864
[TBL] [Abstract][Full Text] [Related]
53. Structure, measurement, and secretion of human glucagon-like peptide-2.
Hartmann B; Johnsen AH; Orskov C; Adelhorst K; Thim L; Holst JJ
Peptides; 2000 Jan; 21(1):73-80. PubMed ID: 10704722
[TBL] [Abstract][Full Text] [Related]
54. Progesterone receptor immunoreactivity in pancreatic endocrine tumors. An immunocytochemical study of 156 neuroendocrine tumors of the pancreas, gastrointestinal and respiratory tracts, and skin.
Viale G; Doglioni C; Gambacorta M; Zamboni G; Coggi G; Bordi C
Cancer; 1992 Nov; 70(9):2268-77. PubMed ID: 1356613
[TBL] [Abstract][Full Text] [Related]
55. Multiple nonfunctional pancreatic islet cell tumor in multiple endocrine neoplasia type I. A case report.
Takahashi H; Nakano K; Adachi Y; Aoki N; Hajiro K; Yamamoto T; Higashizawa T; Chikugo T; Suzuki T
Acta Pathol Jpn; 1988 May; 38(5):667-82. PubMed ID: 2905567
[TBL] [Abstract][Full Text] [Related]
56. On the contamination of commercially available aprotinins with pancreatic islet peptides.
Baldissera FG; Holst JJ
Scand J Clin Lab Invest; 1984 Nov; 44(7):669-72. PubMed ID: 6085188
[TBL] [Abstract][Full Text] [Related]
57. Radioimmunoassay in diagnosis, localization and treatment of endocrine tumours in gut and pancreas.
Rehfeld JF
Scand J Gastroenterol Suppl; 1979; 53():33-8. PubMed ID: 225784
[TBL] [Abstract][Full Text] [Related]
58. Types of pancreatic islet cells and their immunocytochemical identification.
Erlandsen SL
Monogr Pathol; 1980; 21():140-55. PubMed ID: 6163978
[TBL] [Abstract][Full Text] [Related]
59. Development of colonic and pancreatic endocrine tumours in mice expressing a glucagon-SV40 T antigen transgene.
Asa SL; Lee YC; Drucker DJ
Virchows Arch; 1996 Mar; 427(6):595-606. PubMed ID: 8605571
[TBL] [Abstract][Full Text] [Related]
60. Ontogeny of immunoreactive glicentin in the human gastrointestinal tract and endocrine pancreas.
Leduque P; Moody AJ; Dubois PM
Regul Pept; 1982 Oct; 4(5):261-74. PubMed ID: 6758057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
